missouri medicaid glp 1 KFF's survey of officials found 16 state Medicaid programs covered GLP-1s for obesity treatment as of October 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC With Mass. cutting weight loss

Then, we evaluated L-carnitine-attributed effects by comparing VPA elimination half-lives and time-courses of blood lactate levels and organ dysfunction [assessed by the Sequential Organ Failure Assessment (SOFA) score] between matched L-carnitine-treated and non-treated patients using a multivariate analysis including a propensity score

But with a shortage of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) since 2022, the U.S

The FDA has granted the drug an Emergency Use Authorization for the treatment of hospitalized patients with severe COVID-19, however the authorization is temporary

Established cardiovascular disease: The proven cardiovascular protection makes GLP-1 medications first-choice treatment for patients with heart disease